Detalhe da pesquisa
1.
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.
Gynecol Oncol
; 140(2): 259-63, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731723
2.
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.
Int J Gynecol Cancer
; 25(9): 1724-30, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397156
3.
Bladder and bowel symptoms in cervical and endometrial cancer survivors.
Psychooncology
; 23(6): 672-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481859
4.
Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study.
Gynecol Oncol
; 129(1): 81-5, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352917
5.
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.
Gynecol Oncol
; 130(1): 19-24, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623830
6.
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
Gynecol Oncol
; 131(1): 207-12, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23877012
7.
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.
Gynecol Oncol
; 128(2): 155-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201592
8.
Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancers.
Am J Obstet Gynecol
; 208(6): 501.e1-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23507546
9.
Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.
Am J Obstet Gynecol
; 209(6): 576.e1-576.e16, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23933223
10.
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Gynecol Oncol
; 124(1): 119-24, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22032837
11.
Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity.
Int J Gynecol Cancer
; 22(6): 960-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22740002
12.
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
Cytotherapy
; 13(1): 98-107, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20849361
13.
Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
Gynecol Oncol
; 120(2): 265-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145100
14.
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
Gynecol Oncol
; 121(1): 112-7, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21239048
15.
A prospective, randomized trial of integrative medicine for women with ovarian cancer.
Gynecol Oncol
; 123(2): 346-50, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21864886
16.
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
Cancer Chemother Pharmacol
; 88(5): 825-836, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324028
17.
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers.
Cancer Immunol Immunother
; 59(12): 1877-1884, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20820775
18.
Learning about ovarian cancer at the time of diagnosis: video versus usual care.
Gynecol Oncol
; 119(2): 370-5, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20673972
19.
A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer.
Gynecol Oncol
; 113(2): 205-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19239974
20.
Vulvar cancer in young women: demographic features and outcome evaluation.
Am J Obstet Gynecol
; 200(6): 645.e1-5, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19286150